Recombinant Human SUMO3

Description

EnkiLife provides the Recombinant Human SUMO3 protein,aslo know as Small Ubiquitin-Related Modifier 3,SUMO-3,SMT3 Homolog 1,SUMO-2,Ubiquitin-Like Protein SMT3B,Smt3B,SUMO3,SMT3B,SMT3H1, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Small Ubiquitin-Related Modifier 3 is produced by our E.coli expression system and the target gene encoding Met1-Phe103 is expressed.Accession:P55854. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:11.6 KDa. Background:SUMO3 belongs to the SUMO protein family and operates like ubiquitin. Ubiquitin-like protein which can be covalently attached to target lysines either as a monomer or as a lysine-linked polyer. Nevertheless unlike ubiquitin that targets proteins for degration, SUMO3 takes part in several cellular processess, such as nuclear transport, transcription regulation, apoptosis and protein stability. SUMO3 participates in amyloid beta generation and has a key role in the oneset or progression of Alzheimers disease.